Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19667251 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)
Condition: Hypertension
Interventions: Drug: Olmesartan medoxomil +Azelnidipine;   Drug: Olmesartan medoxomil + Hydrochlorothiazide

Indicates status has not been verified in more than two years